Oracle
ORCL
Salesforce
CRM
Microsoft
MSFT
Cisco
CSCO
Broadcom
AVGO
US Stock MarketDetailed Quotes
FHTX Foghorn Therapeutics
- 4.650
- -0.040-0.85%
Close Jan 8 16:00 ET
258.51MMarket Cap-2.51P/E (TTM)
4.790High4.630Low90.37KVolume4.680Open4.690Pre Close422.01KTurnover0.35%Turnover RatioLossP/E (Static)55.59MShares10.25052wk High-9.14P/B121.15MFloat Cap2.70052wk Low--Dividend TTM26.05MShs Float28.265Historical High--Div YieldTTM3.41%Amplitude2.700Historical Low4.670Avg Price1Lot Size
About Foghorn Therapeutics Company
Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Through its scalable Gene Traffic Control product platform, the firm is systematically interrogating and drugging the chromatin regulatory system. The company was founded by Cigall Kadoch, Gerald W. Crabtree and Douglas G. Cole in October 2015 and is headquartered in Cambridge, MA.
Company Profile
SymbolFHTX
Company NameFoghorn Therapeutics
Listing DateOct 23, 2020
Issue Price16.00
Founded2015
CEOMr. Adrian Gottschalk
MarketNASDAQ
Employees116
Fiscal Year Ends12-31
Address500 Technology Square,Suite 700
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-586-3100
Websitehttp://www.foghorntx.com
Company Executives
- Name
- Position
- Salary
- Adrian Gottschalk
- Chief Executive Officer and Director
- 2.50M
- Michael J. LaCascia
- Chief Legal Officer
- --
- Dr. Steven F. Bellon, PhD
- Chief Scientific Officer
- 1.19M
- Kristian F. Humer
- Chief Financial Officer and Principal Accounting Officer
- --
- Carlos Costa
- Chief People Officer
- --
- Dr. Alfonso Quintas-Cardama
- Chief Medical Officer
- 1.84M
- Fanny Cavalie
- Chief Strategy and Business Operations Officer
- --
- Dr. Douglas G. Cole, M.D.
- Chairman of the Board
- 184.57K
- Dr. Scott Biller, PhD
- Independent Director
- 145.57K
- Dr. Thomas J. Lynch
- Independent Director
- 145.57K
- B. Lynne Parshall, Esq.,J.D.
- Independent Director
- 157.65K
- Ian F. Smith
- Independent Director
- 141.57K
- Dr. Michael Mendelsohn, M.D.
- Independent Director
- 154.57K
- Dr. Balkrishan Gill, PhD
- Independent Director
- 159.07K
- Stephen J. DiPalma
- Treasurer
- --
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.